Helena Sjödin

641 total citations
13 papers, 392 citations indexed

About

Helena Sjödin is a scholar working on Otorhinolaryngology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Helena Sjödin has authored 13 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Otorhinolaryngology, 5 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Helena Sjödin's work include Head and Neck Cancer Studies (12 papers), Salivary Gland Tumors Diagnosis and Treatment (3 papers) and Cancer Diagnosis and Treatment (3 papers). Helena Sjödin is often cited by papers focused on Head and Neck Cancer Studies (12 papers), Salivary Gland Tumors Diagnosis and Treatment (3 papers) and Cancer Diagnosis and Treatment (3 papers). Helena Sjödin collaborates with scholars based in Sweden. Helena Sjödin's co-authors include Freddi Lewin, Rolf Lewensohn, G. E. F. Lundell, Roger Tell, Bo Nilsson, Jan Nyman, Signe Friesland, Christer Lindholm, Johan Hansson and Henrik Møller and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Helena Sjödin

12 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helena Sjödin Sweden 7 210 185 109 92 77 13 392
I. Toledano France 6 127 0.6× 77 0.4× 143 1.3× 95 1.0× 17 0.2× 16 287
Pierre Boisselier France 11 173 0.8× 96 0.5× 257 2.4× 112 1.2× 10 0.1× 22 520
Nam Kwon Lee South Korea 11 26 0.1× 166 0.9× 93 0.9× 143 1.6× 17 0.2× 34 396
Gabriel Calzada United States 9 207 1.0× 144 0.8× 59 0.5× 210 2.3× 76 1.0× 13 402
Tosol Yu South Korea 9 68 0.3× 137 0.7× 99 0.9× 67 0.7× 17 0.2× 21 326
Minh Thi Tieu Australia 10 59 0.3× 86 0.5× 50 0.5× 61 0.7× 11 0.1× 16 345
Kotaro Terashima Japan 11 36 0.2× 140 0.8× 203 1.9× 100 1.1× 7 0.1× 22 434
Carlo Furlan Italy 13 88 0.4× 180 1.0× 252 2.3× 98 1.1× 5 0.1× 29 515
Gokoulakrichenane Loganadane France 10 101 0.5× 126 0.7× 164 1.5× 76 0.8× 12 0.2× 39 374
Katrina Andrews United Kingdom 6 23 0.1× 71 0.4× 119 1.1× 79 0.9× 13 0.2× 10 365

Countries citing papers authored by Helena Sjödin

Since Specialization
Citations

This map shows the geographic impact of Helena Sjödin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helena Sjödin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helena Sjödin more than expected).

Fields of papers citing papers by Helena Sjödin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helena Sjödin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helena Sjödin. The network helps show where Helena Sjödin may publish in the future.

Co-authorship network of co-authors of Helena Sjödin

This figure shows the co-authorship network connecting the top 25 collaborators of Helena Sjödin. A scholar is included among the top collaborators of Helena Sjödin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helena Sjödin. Helena Sjödin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Gebre‐Medhin, Maria, Gabriel Adrian, Per Engström, et al.. (2025). Chemoradiation therapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer—Mature Results of the ARTSCAN III Trial. International Journal of Radiation Oncology*Biology*Physics. 123(3). 681–690.
3.
Högmo, Anders, Helena Sjödin, Maria Gebre‐Medhin, et al.. (2021). A national study of health‐related quality of life in patients with cancer of the base of the tongue compared to the general population and to patients with tonsillar carcinoma. Head & Neck. 43(12). 3843–3856. 6 indexed citations
4.
Gebre‐Medhin, Maria, Eva Brun, Per Engström, et al.. (2020). ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer. Journal of Clinical Oncology. 39(1). 38–47. 98 indexed citations
5.
Mercke, Claes, Þröstur Björgvinsson, Anders Berglund, et al.. (2020). Modeling of Xerostomia After Radiotherapy for Head and Neck Cancer: A Registry Study. Frontiers in Oncology. 10. 1647–1647. 11 indexed citations
6.
Holmberg, Erik, Jan Nyman, Anders Högmo, et al.. (2020). Swedish National Multicenter Study on Head and Neck Cancer of Unknown Primary: Prognostic Factors and Impact of Treatment on Survival. International Archives of Otorhinolaryngology. 25(3). e433–e442. 8 indexed citations
7.
Högmo, Anders, Helena Sjödin, Maria Gebre‐Medhin, et al.. (2020). Health‐related quality of life among tonsillar carcinoma patients in Sweden in relation to treatment and comparison with quality of life among the population. Head & Neck. 42(5). 860–872. 3 indexed citations
8.
Zackrisson, Björn, Elisabeth Kjellén, Karin Söderström, et al.. (2015). Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma – The ARTSCAN trial. Radiotherapy and Oncology. 117(1). 99–105. 23 indexed citations
9.
Mercke, Claes, Helena Sjödin, Gunnar Adell, et al.. (2011). Survival, tumor control, and toxicity with TPF before accelerated radiotherapy potentiated with cetuximab for stage III-IV unresectable head and neck cancer: A phase II study.. Journal of Clinical Oncology. 29(15_suppl). 5552–5552. 1 indexed citations
10.
Mercke, Claes, et al.. (2009). Upfront chemotherapy and accelerated radiotherapy with EGFR inhibition for locally advanced inoperable head and neck cancer. Journal of Clinical Oncology. 27(15_suppl). 6040–6040. 4 indexed citations
11.
Lindholm, Christer, Monika Dufmats, Johan Hansson, et al.. (2004). Invasive cutaneous malignant melanoma in Sweden, 1990–1999. Cancer. 101(9). 2067–2078. 83 indexed citations
12.
Tell, Roger, G. E. F. Lundell, Bo Nilsson, et al.. (2004). Long-term incidence of hypothyroidism after radiotherapy in patients with head-and-neck cancer. International Journal of Radiation Oncology*Biology*Physics. 60(2). 395–400. 81 indexed citations
13.
Tell, Roger, Helena Sjödin, G. E. F. Lundell, Freddi Lewin, & Rolf Lewensohn. (1997). Hypothyroidism after external radiotherapy for head and neck cancer. International Journal of Radiation Oncology*Biology*Physics. 39(2). 303–308. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026